Navigation Links
Bed bugs are not repelled by commercial ultrasonic frequency devices
Date:12/10/2012

Alternative means of controlling urban insect pests by using ultrasonic frequencies are available and marketed to the public. However, few of these devices have been demonstrated as being effective in repelling insect pests such as mosquitoes, cockroaches, or ants. Despite the lack of evidence for the efficacy of such devices, they continue to be sold and new versions targeting bed bugs are readily available.

However, according to a soon-to-be-published article in the Journal of Economic Entomology, commercial devices that produce ultrasound frequencies are NOT promising tools for repelling bed bugs. In "Efficacy of Commercially Available Ultrasonic Pest Repellent Devices to Affect Behavior of Bed Bugs (Hemiptera: Cimicidae)," , authors K. M. Yturralde and R. W. Hofstetter report the results of their tests of four commercially available electronic pest repellent devices designed to repel insect and mammalian pests by using sound.

The devices, which were purchased online, were used according to manufacturers' instructions. A sound arena was created for each ultrasonic device, in addition to a control arena which featured no sound. However, the authors found that there were no significant differences in the number of bed bugs observed in the control (no sound) and sound arenas, and that bed bugs were neither deterred nor attracted to the arena with the sound device.

The authors conclude that the ultrasonic devices may not have deterred or attracted bed bugs because they may not have produced the right combination of frequencies. Bed bugs are commonly exposed to frequencies made by their host species (humans) and by appliances and machines found in homes. Therefore, it may be possible that bed bugs also would exploit sounds made by their human hosts, such as breathing or snoring. Future studies of bed bug bioacoustics may be served well by using low-frequency sounds produced by host species.


'/>"/>
Contact: Richard Levine
rlevine@entsoc.org
301-731-4535
Entomological Society of America
Source:Eurekalert

Page: 1

Related biology news :

1. NIST focuses on testing standards to support lab on a chip commercialization
2. Sandia seeks commercial partners for revolutionary SpinDx medical diagnostic tool
3. Researchers take hibiscus efforts to commercialization
4. A study confirms that long commercials evoke stronger emotions
5. Kessler Foundation implements Ekso Bionics first commercial robotic exoskeleton
6. Soft Robotics: A groundbreaking new journal on engineered soft devices that Interact with Living Systems
7. Simplifying heart surgery with stretchable electronics devices
8. Medical devices powered by the ear itself
9. Tattoo-like devices for wireless pregnancy monitoring
10. NJIT professor awarded patent today for new desalination devices, more
11. Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2016)... IRVINE, Calif. , Nov. 23, 2016 ... help endurance athletes and their trainers non-invasively measure ... Variability Index, Pulse Rate, and Respiration Rate in approximately ... Ember enables users easy and immediate access to key ... as part of a training regimen. ...
(Date:11/21/2016)... Lithuania , Nov. 21, 2016   ... and object recognition technologies, today announced that the ... smart cards was submitted for the NIST ... successfully passed all the mandatory steps of the ... evaluation is a continuing test of fingerprint templates ...
(Date:11/17/2016)... 2016  AIC announces that it has just released a new white paper authored ... scale-out plus high speed data transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... , Dec. 2, 2016 Amgen (NASDAQ: ... today announced the submission of a Marketing Authorization Application (MAA) ... biosimilar candidate to Avastin ® (bevacizumab). The companies believe ... the EMA. "The submission of ABP 215 ... to expand our oncology portfolio," said Sean E. Harper ...
(Date:12/2/2016)... Research and Markets has announced the ... and Companies" to their offering. ... , , ... biotechnology industries is anticipated. Nanotechnology will be applied at all ... to diagnostic applications in clinical trials. Many of the assays ...
(Date:12/2/2016)... ... December 01, 2016 , ... ... value of DNA microarray comparative genomic hybridization (array CGH) for HER2 genomic ... Symposium. Using molecular test results from tumors with previously documented positive, negative, ...
(Date:12/2/2016)... ... December 01, 2016 , ... ... Symposium (CSS) and the popularity of US Single Day Events (SDE) to organize ... early Summer 2018, in Raleigh, NC. Topics of the pharmaceutical and life sciences ...
Breaking Biology Technology: